1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. NovoCure Limited
  6. Calendar
    NVCR   JE00BYSS4X48

NOVOCURE LIMITED

(NVCR)
  Report
Delayed Nasdaq  -  04:00 2022-07-01 pm EDT
73.30 USD   +5.47%
07/01Novocure to Report Second Quarter 2022 Financial Results
BU
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Index
CI
06/24NOVOCURE LIMITED(NASDAQGS : NVCR) added to Russell 2500 Growth Index
CI
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Event chart NOVOCURE LIMITED
Upcoming events on NOVOCURE LIMITED
07/28/22 Interim 2022 Earnings Release
07/28/22 | 08:00am Interim 2022 Earnings Call
10/27/22 Q3 2022 Earnings Release (Projected)
02/23/23 FY 2022 Earnings Release (Projected)
04/27/23 Q1 2023 Earnings Release (Projected)
07/27/23 Interim 2023 Earnings Release (Projected)
Past events on NOVOCURE LIMITED
06/08/22 | 09:00am Annual General Meeting
04/28/22 | 08:00am Q1 2022 Earnings Call
04/28/22 | 07:00am Q1 2022 Earnings Release
04/08/22 American Association of Cancer Research Meeting - Abstract No CT234
04/08/22 American Association of Cancer Research Meeting - Abstract No 4138
04/08/22 American Association of Cancer Research Meeting - Abstract No 3447
04/08/22 American Association of Cancer Research Meeting - Abstract No 1801
04/08/22 American Association of Cancer Research Meeting - Abstract No 2659
04/08/22 American Association of Cancer Research Meeting - Abstract No 1866
04/08/22 American Association of Cancer Research Meeting - Abstract No 299
Past dividends on NOVOCURE LIMITED

- No events available -

Annual results
Fiscal Period : December201720182019202020212022
Sales
M $
Released
Forecast
Spread
177
177
0,00%
248
247
0,51%
351
351
0,05%
494
494
0,14%
535
539
-0,81%
 
552
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
-31,7
-10,5
-200%


 
7,55
9,20
-18%
39,6
40,3
-1,9%
-34,1
-20,6
-66%
 
-44,4
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-39,3
-42,3
7,0%
-33,7
-31,7
-6,3%
-0,91
6,79
-113%
30,4
34,9
-13%
-44,3
-28,8
-54%
 
-47,9
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-48,5
-53,3
9,0%
-45,9
-44,6
-3,0%
-8,82
-2,12
-316%
18,1
25,8
-30%
-52,1
-36,7
-42%
 
-58,3
 
Net income
M $
Released
Forecast
Spread
-61,7
-59,9
-2,9%
-63,6
-61,3
-3,7%
-7,23
-10,5
31%
19,8
28,8
-31%
-58,4
-41,1
-42%
 
-62,6
 
EPS
$
Released
Forecast
Spread
-0,70
-0,68
-3,1%
-0,69
-0,65
-5,7%
-0,07
-0,10
32%
0,20
0,26
-24%
-0,56
-0,41
-37%
 
-0,58
 
Announcement Date02/22/201802/28/201902/27/202002/25/202102/24/2022-
Quarterly results
Fiscal Period : December2021 Q12021 Q22021 Q32021 Q42022 Q12022 Q2
Sales
M $
Released
Forecast
Spread
135
139
-3,3%
134
142
-5,9%
134
141
-5,4%
133
134
-0,95%
138
134
2,4%
 
135
 
Operating income
(EBITDA)
M $
Released
Forecast
Spread
2,28
9,27
-75%
-9,82
4,92
-300%
-5,82
-5,96
2,4%
-20,7
-4,23
-390%
1,80
-20,3
109%
 
-11,6
 
Operating profit
(EBIT)
M $
Released
Forecast
Spread
-0,09
2,72
-103%
-12,3
2,79
-541%
-8,55
-6,34
-35%
-23,4
-7,85
-198%
-0,81
-18,4
96%
 
-13,4
 
Pre-Tax Profit
(EBT)
M $
Released
Forecast
Spread
-2,73
3,43
-180%
-13,2
2,10
-729%
-10,5
-7,76
-36%
-25,6
-10,2
-151%
-2,52
-22,1
89%
 
-15,0
 
Net income
M $
Released
Forecast
Spread
-4,13
2,26
-283%
-14,6
1,23
-1 286%
-13,1
-7,57
-73%
-26,5
-11,1
-138%
-4,65
-19,9
77%
 
-15,4
 
EPS
$
Released
Forecast
Spread
-0,04
0,02
-278%
-0,14
0,01
-1 698%
-0,13
-0,07
-76%
-0,25
-0,11
-134%
-0,04
-0,19
79%
 
-0,14
 
Announcement Date04/29/202107/29/202110/28/202102/24/202204/28/2022-
Previous year Next Year
Upcoming sector events for NOVOCURE LIMITED
More events
Past sector events for NOVOCURE LIMITED
More events
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise